Sio Capital Management, LLC 13D/13G Filings for Aprea Therapeutics, Inc. (APRE)

Sio Capital Management, LLC 13D and 13G filings for Aprea Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-08
3:14 pm
Sale		 2025-03-31 13G Aprea Therapeutics, Inc.
APRE		 Sio Capital Management, LLC 276,603
5.040%		 -3,397decrease
(-1.21%)		 Filing
2024-02-14
08:00 am
Purchase		 2023-12-31 13G Aprea Therapeutics, Inc.
APRE		 Sio Capital Management, LLC 280,000
7.490%		 280,000increase
(New Position)		 Filing